Skip to main content
. 2020 Apr 1;10(4):1085–1102.

Figure 2.

Figure 2

Schematic summary of HCC classification according to the immune landscape in the tumor microenvironment. This classification defines two clusters based on the immune landscape and clinical characteristics, the responsive cluster and the resistant cluster, each of which is characterized by distinct immune-related parameters and might present a different response rate to immune checkpoint therapy.